Category Archives: Human Longevity

While everyone wants to live a long and healthy life, it isn't possible for everyone. However, recent research has highlighted the significance of the tumour suppressor protein PTEN that can increase your health span, when targeted to create therapies to promote a longer life span. This study was conducted under Professor Seung-Jae V. Lee from the Department of Biological Sciences.

It was published in the 'Nature Communications Journal'.

Insulin and insulin-like growth factor-1 (IGF-1) signalling (IIS) is one of the evolutionarily conserved ageing-modulatory pathways present in life forms ranging from tiny roundworms to humans. The proper reduction of IIS leads to longevity in animals but often causes defects in multiple health parameters including impaired motility, reproduction and growth.

The PTEN protein is a phosphatase that removed phosphate from lipids as well as proteins. Interestingly, the newly identified amino acid changed delicately recalibrated the IIS by partially maintaining protein phosphatase activity while reducing lipid phosphatase activity.

As a result, the amino acid change in the PTEN protein maintained the activity of the longevity-promoting transcription factor Forkhead Box O (FOXO) protein while restricting the detrimental upregulation of another transcription factor, NRF2, leading to long and healthy life in animals with reduced IIS.

Professor Seung-Jae V. Lee said, "Our study raises the exciting possibility of simultaneously promoting longevity and health in humans by slightly tweaking the activity of one protein, PTEN."

Read this article:
How to increase life span? Researchers find a way - ETHealthworld.com

Diversity brings in new ideas and acts as a pathway to unlock creativity. The business world is no exception. The more a organization is open to perspectives from people of different backgrounds, the more creative and resilient it becomes. Diversity not only improves performance but also creates positive friction that enhances deliberation and upends conformity. However, it is not as easy to embrace diversity than to merely say. If not deployed carefully, an organization could suffer from friction, uneasiness, and conflicts.

We asked entrepreneurs from the World Economic Forums Technology Pioneers to share their views on why diversity is so important to their organizations and what were learnings from their entrepreneurial journey. Here is what they said:

Aba Schubert (CEO, Dorae)

I have valued diversity since I first started school at the age of five. Suddenly my world opened up each day I worked, played and bumped up against people who were not like me for one reason or another. I learned as much from the people around me as from class. At its core, diversity feeds a curious mind. The more differences of perspective and experience we can gather around us, the more we can know.

At Dorae, having a diverse team means we connect the dots in new ways, because we can borrow novel perspectives from each other and build on an experience set that spans the world and generations. Being part of a team-of-all-types that supplies software for global trade is like the first day of school writ large. We learn as much from each other and from our wildly diverse market as we ever learnt from studying.

Bryan Dechairo (CEO, Sherlock Biosciences)

At Sherlock, Diversity, Equity, and Inclusion are not just buzz words; they are part of our core values. We believe that a community of well rounded professionals from all ethnicities, nationalities, educational backgrounds, and genders fosters an environment of new ideas and innovation. But for too long, structural biases have prevented certain communities from access to opportunities within the biotech industry. Recognizing that these barriers exist, we have committed to creating pathways to overcome them. Weve worked to ensure our company reflects the diversity of our community and provides a voice to those that have been denied one for too long.

While diversity has always been a priority for us, the pandemic undoubtably shone a light on long existing inequities in care within our healthcare systems, inequities that can no longer be ignored. It became a catalyst for us, amplifying the responsibility we felt to be a voice in the industry calling for others to rise to the challenge of ensuring diversity and health equity within their organizations, communities and the world.

Charles Bark (Founder and CEO, HiNounou)

Diversity is a huge richness especially for a startup who has a vision to go worldwide and impact the life of people in all continents. Since HiNounou aims to bring healthy longevity to seniors and their families worldwide and ease the burden of the professional caregivers, we consider that is vital to have diversity in our team.

As shown in the World Economic Forum Strategic Intelligence Platform for ageing and longevity, building healthy longevity for well developed countries as well as emerging countries is a real challenge. It involves stakeholders looking at technology innovation, research regarding intergenerational relationships to smart cities and healthy nutrition diets, among other factors.

For us, diversity wasn't just an option but a key success factor. Diversity helps us to gather wonderful people in our HiNounou team of humanistic leaders who want to make the world better. We currently have a fantastic team in 4 continents. We expanded our offer in 12 countries within a short period of 2 years. Thanks to the World Economic Forum, we aim to impact the world and shape the future of health, aging and longevity and impact the life of billion people.

Karim Cassimjee (CEO and Cofounder, EnginZyme)

To achieve our ambitious goals we need to not only attract the best and brightest people in their field, but more importantly the people that are the best fit for the company. One of the most important success factors is the strong culture and people being aligned with our company culture. Even if we are a Swedish startup, our team is very international and built with people from many countries (Swedes are actually a minority). By attracting people that share similar ideas and mindset and with diverse backgrounds we have created a culture of inclusiveness where people feel safe to be themselves and to take initiatives. We are very proud of the team and appreciate that we have a very loyal workforce.

Kasim Alfalahi (CEO, Avanci)

Our business is truly global, we work with both Fortune 100 companies and very small businesses, in dozens of countries around the world and across diverse cultures and organizational setups. Throughout my career, Ive worked in and led a variety of teams. My experience has been that the more diverse the team, the richer the ideas and the solutions which can be created Ive seen firsthand that different cultures may view the same issue from a different perspective.

Most of us in Avanci had worked for multinational businesses before and learned the value of being more closely aligned with our customers. So, when we founded Avanci, we wanted to reflect more closely the diverse world in which we operate. Though it would perhaps have been easier just to work from a single location, instead we looked to be physically closer to our counterparts. We now work across five different offices, one in the US, one in Europe and three in Asia.

Across Avanci, and our sister company Marconi which supports us, the nationalities, race, gender and age of our people are as diverse as they are among our clients. We recruit the best people for the job without any other considerations. This year to date, 50% of our new hires are women, and our new colleagues reflect five nationalities across four countries. I believe that by embracing and celebrating diversity we can be a more effective organization and a great place to work!

Amos Haggiag (CEO and Cofounder, Optibus)

Every city and region struggle with unique industry challenges. Understanding local problems, developing localized and innovative solutions, and breaking into new markets requires a diverse team with expertise in and knowledge of different cultures, languages, and geographies.

Optibus works with transportation providers in over 500 cities across twenty four countries, so team diversity is key to our understanding and tackling of local transportation issues worldwide. When we looked at public transportation in rapidly urbanizing areas of Africa, Latin America, and India - places that are poised to be the cities of the future - we detected a huge opportunity for using AI and data driven technology to create efficient, equitable, and sustainable mobility systems from the beginning of their development. Of course, given the diversity of these regions, we knew we could only identify and resolve local problems with local expertise, starting with the optimization of South Africas minibus taxi industry.

Chrissa McFarlane (Founder and CEO, Patientory)

I believe that gender, racial, geographic, and cultural diversity are important to every organization and play a significant role in business growth. It is all about creating an inclusive environment, accepting of every individuals differences, allowing all employees to achieve their full potential and as a result allowing your business to achieve its fullest potential. It gives you access to a greater range of talent from all over the world and provides insights into the needs and motivations of all your customer or client base, rather than just a small part of it.

For me, I have always recognized the value of diversity and how beneficial it can be to a company's growth. Thats why Patientory, my startup, works to uphold a culture that prioritizes both our work and employees. Prioritizing both within our culture allows us to complete our best work. In fact, our team is a group of individuals from different backgrounds and parts of the world. We are a small yet highly collaborative team working to improve population health outcomes. We realize improving health starts internally with our company workflow.

Natalia Karayaneva (CEO, Propy)

Diversity and inclusion are essential in business today as a healthy variety of people from different backgrounds and cultures provides us with the balance of voices and diversity of thought that we need. Having a working environment filled with employees of different backgrounds, skills, cultures, experiences, and knowledge means that there is an increase in innovative and creative ideas. Minority led organizations are prone to always go the extra mile. I believe a diversified organization encourages personal growth and development. We have employees from all over the world - USA, Bulgaria, Ukraine, Russia. Propy is female led, and we have always seen this as one of our biggest strengths and this is the DNA of the company.

Daniel Nathrath (Founder and CEO, Ada Health)

At Ada, diversity and accessibility is a fundamental part of our mission. We believe that everyone, everywhere, should have access to trusted medical guidance that is relevant, actionable and effective. Our cofounding team came together with a shared understanding that AI in healthcare is only as good as the people and data it learns from. We knew that in order to build an inclusive and well balanced AI solution that would have a tangible, significant impact on human health at a global scale, we had to ensure diversity within the medical and technical teams we brought on to build Ada from the very beginning.

When we launched our Global Health Initiative, which aims to improve access to care for the worlds most underserved and vulnerable populations, the importance of diversity became even clearer. Finding local partners, and listening to their experiences, was essential, and we put a huge amount of work into not only translating but also localizing Ada for new languages and regions in order to maximise our impact. It was an important reminder that every person, every race, every country, is different, and that if we want to deliver impactful, personalized health experiences for all, we cant do that without diversity.

Bhakti Vithalani (Founder and CEO, BigSpring)

Our mission at BigSpring is to create equality by closing the skills gap. This is a truly global challenge, which is why diversity in all its forms is the core value of our organization. The skills gap impacts everyone, so we need BigSpring as a company to represent the people were here to serve - everyone. Our clients and learners can be anywhere in the world, so our teams mirror this geographic diversity. We have team members in Singapore, India, Argentina and the US, speaking over a dozen languages. Working across the globe, cultural diversity at BigSpring is the key to not just helping us understand how skilling can improve peoples lives but empathise and relate to the diverse populations were serving. Were a female founded company where women represent the majority of our leadership team.

My Aha moment is something that happens daily. No matter who Im speaking to, where theyre located or what their background is, Ive found that there is someone on the team at BigSpring that understands where they are coming from. Understanding any challenge starts with understanding the people it impacts. The more we have in common, the more we understand each other.

Meirav Oren (CEO and Cofounder, Versatile)

Versatile has implemented more diversity within their company by enabling and empowering builders to build with the power of data. Data driven decisions allows for less and well controlled overtime, fewer unnecessary steps, and higher levels of safety and predictably. Versatile believes the first step for any improvement is measuring and setting the bar to unlock the future.

Continue reading here:
Why diversity within your organization matters fundamentally | World Economic Forum - World Economic Forum

Tom Brady is arguably the greatest player to have ever graced the fields of NFL. Name any record or top 5 lists, and one mans name is certain to be there Tom Brady.

ADVERTISEMENT

Article continues below this ad

While his on-field performances and longevity certainly make him amongst the best in the game, what makes people call him the G.O.A.T has been his professionalism. The Tampa Bay quarterback is known for his behavior, which is why his recent actions sent shock waves across the NFL.

ADVERTISEMENT

Article continues below this ad

Tampa Bay Buccaneers started this season on a roll, raking up five consecutive wins. Ever since then, they seem to have fallen off a cliff winning only 1 game in their last three matches.

After the frustrating 29-19 loss against the Washington Football club, the former New England Patriots quarterback was visibly upset. It almost felt like he was uninterested in giving an interview. Hence, he asked the reporters to be quick and replied in one liners.

Make it quick, Brady said post-game on Sunday. We started with the ball. They came away with it, he said.He then tried walking off the podium before a reporter asked him to stay.What else? Brady asked. The GOAT was definitely p*ssed!

Tom Brady is as perfect a human can get but to be human is to err. After the loss against the Washington Football Club, the Tampa Bay Buccaneers quarterback was visibly frustrated.Speaking on his Lets Go podcast, the quarterback revealed the reason why he gave a cold shoulder to the media with a very relatable metaphor involving office-email-coffee.

ADVERTISEMENT

Article continues below this ad

Press conferences after a loss are like co-workers emailing you before youve had your coffee I mean I dont drink coffee, but I imagine thats what its like.. he said

ADVERTISEMENT

Article continues below this ad

Even the GOAT has off days!

DIVE DEEPER

Tom Brady Deems Legendary Feat He Achieved As Impossible to Repeat in NFL

4 days ago

Original post:
Tom Brady Reveals the Real Reason Behind His Frustration During Press Conference After Washington Humiliation - EssentiallySports

Guilford County Attorney Mark Payne is stepping down from that job at the end of the year.

Payne made the announcement at the Thursday, Nov. 18 Board of Commissioners meeting before he thanked the commissioners for their support over the past dozen years. Two days earlier, Payne had informed the employees in the countys legal department along with other select county officials of his decision which took many by complete surprise.

Payne said he felt it was the right time for him to be making the exit after 12 years.

Payne has achieved the somewhat amazing accomplishment of having served 12 times longer than the previous six county attorneys combined. (Before Payne took the job with Guilford County, the county burned through six different county attorneys in less than a year.)

The fact that the county had a half dozen county attorneys in the year before Payne arrived is an indication of just how difficult that job is. Guilford County attorneys work directly for the Board of Commissioners which means they have nine bosses who span the political spectrum and often have widely varying views of what should be done. When Payne took the job with Guilford County, he had 11 bosses because the redistricting a decade ago hadnt yet shrunk the board by two.

He came to Guilford County in October of 2009 after serving as the Johnston County Attorney in Smithfield for 13 years.

Payne said after the Nov. 17 meeting that he plans to remain in Greensboro and he added that he will be available for call back part-time work if the county needs his services in 2022.

Payne said he recently looked at the years hed put into government work and found that he did now qualify for a full 30 years. He said he discussed the matter first with Guilford County Human Resources Department, and, after thinking about it and getting his questions answered, he decided this would be a good time to step down.

He said hed now like to spend more time with his family and also like to do things like perhaps go to the Final Four in 2022, which is in the New Orleans Superdome. Payne, who attended UNC-Chapel Hill as an undergraduate and then went to law school there as well, is a big Tarheel fan.

Read the original post:
Guilford County Attorney Mark Payne Retires - The Rhino Times of Greensboro - The Rhino TImes

Very old flies cease to age, at least under the definition of aging as the rise of mortality rate with age. Very old flies have a high mortality rate, but that rate plateaus. There has been some back and forth over the years as to whether such a late life plateau in mortality rates can be observed in humans. Presently the consensus is that it is not apparent. It is, however, challenging to draw any robust conclusions on human mortality past the age of 110, as there are so very few survivors to that late stage of life. All of this is fascinating from a scientific point of view, but something of a sideshow when it comes to the treatment of aging as a medical condition. Earnest therapies for aging are needed at half the age of interest here, and given good approaches to repair the underlying damage of aging, it becomes somewhat irrelevant as to what happens when those therapies are not used.

The validity of conclusions about mortality at extreme age depends crucially on the quality of the data on which they are based, as age misrepresentation for the very old is common even in countries with otherwise reliable statistical data. Motivated by this, demographic researchers from 13 countries contribute to the International Database on Longevity (IDL), the third (August 2021) release of which contained 1119 individually validated life lengths of supercentenarians, i.e. those reaching age 110 or more; the data, which cover different time periods for different countries, can be obtained from http://www.supercentenarians.org. For some countries, the IDL now also includes data on semi-supercentenarians, i.e. people living to an age of at least 105. Since October 2019, IDL has contained French data on 9571 semi-supercentenarians and 241 supercentenarians who died between 1 January 1987 and 31 December 2016. We call these the France 2019 data; all these supercentenarians but only some of the semi-supercentenarians were validated.

We use a combination of extreme value statistics, survival analysis, and computer-intensive methods to analyse the mortality of Italian and French semi-supercentenarians. After accounting for the effects of the sampling frame, extreme-value modelling leads to the conclusion that constant force of mortality beyond 108 years describes the data well and there is no evidence of differences between countries and cohorts. These findings are consistent with use of a Gompertz model and with previous analysis of the International Database on Longevity and suggest that any physical upper bound for the human lifespan is so large that it is unlikely to be approached. Power calculations make it implausible that there is an upper bound below 130 years. There is no evidence of differences in survival between women and men after age 108 in the Italian data and the International Database on Longevity, but survival is lower for men in the French data.

Link: https://doi.org/10.1098/rsos.202097

Go here to see the original:
Analysis of Human Mortality Data at Extreme Old Age from ...

December 10, 2021 9:00am-11:30am Penn Pavilion on Dukes West Campus and streamed via Zoom.

Heather E. Whitson, MD, MHSProfessor of Medicine (Geriatrics) & OphthalmologyDirector, Duke Center for the Study of Aging and Human Development

The Duke Center for the Study of Aging and Human Development is a multi-disciplinary hub for the promotion of healthy aging across the lifespan and management of social and medical complexities in late life. With more than 150 affiliated faculty members from across the University and Medical Center, and millions of dollars annually in aging-related research funding, the Center is a vital national resource for the study of aging.

Current research includes: studies of resilience to late-life stressors; age-related functional decline; genomic, proteomic and metabolomic biomarkers of aging; exercise; osteoporosis; Alzheimers disease; cancer and aging; viral diseases of aging; depression in later life; caregiver stress; and religion/spirituality and health. The Center is also dedicated to advanced training and innovative education for the next generation of gerontologists and geriatricians, and to expanding and enhancing the field of aging-related research at Duke and beyond.

Visit link:
Duke Aging Center Center for the Study of Aging and ...

WELCOME! The Chinese Longitudinal Healthy Longevity Survey (CLHLS) has been supported by NIA/NIH grants R01 AG023627-01 (PI: Zeng Yi) (Grant name: Demographic Analysis of Healthy Longevity in China) and P01 AG 008761 (PI: Zeng Yi; Program Project Director: James W. Vaupel), awarded to Duke University, with Chinese matching support for personnel costs and some local expenses. UNFPA and the China Social Sciences Foundation provided additional support for expanding the 2002 CLHLS survey. The Max Planck Institute for Demographic Research has provided support for international training since the CLHLS 1998 baseline survey. Finally, in December 2004 the China Natural Sciences Foundation and the Hong Kong Research Grants Council (RGC) partnered with NIA/NIH, providing grants to partially support the CLHLS project.

Until present, the CLHLS conducted face-to-face interviews with 8,959, 11,161, 20,428, 18,549 and 20,366, 10,188, and 7,192individuals in 1998, 2000, 2002, 2005, 2008-09, 2011-12, and 2014, respectively, using internationally compatible questionnaires. Among the 96,843interviews conducted in the sevenwaves, 16,547were with centenarians, 22,232with nonagenarians, 25,719with octogenarians, 19,884with younger elders aged 65-79, and 11,461 with middle-age adults aged 35-64. At each wave, survivors were re-interviewed, and deceased interviewees were replaced with new participants. Data on mortality and health status before dying for the 26,236elders aged 65-110 who died between waves were collected in interviews with a close family member of the deceased.

The CLHLS has the largest sample of centenarians in the world according to a report in Science (see the report). Our general goal is to shed new light on a better understanding of the determinants of healthy longevity of human beings. We are compiling extensive data on a much larger population of the oldest-old aged 80-112 than has previously been studied, with a comparison group of younger elders aged 65-79. We propose to use innovative demographic and statistical methods to analyze longitudinal survey data. Our goal is to determine which factors, out of a large set of social, behavioral, biological, and environmental risk factors, play an important role in healthy longevity. The large population size, the focus on healthy longevity (rather than on a specific disease or disorder), the simultaneous consideration of various risk factors, and the use of analytical strategies based on demographic concepts make this an innovative demographic data collection and research project.

Our specific objectives are as follows:

The organizational framework of the CLHLS is summarized as follows:

More:
Chinese Longitudinal Healthy Longevity Survey (CLHLS ...

Aging in humans is a well-established primary risk factor for many disabling diseases and conditions, among them diabetes, cardiovascular disease, Alzheimer's disease and cancer. In fact, the risk of death from these causes is dramatically accelerated (100-1000 fold) between the ages of 35 and 85 years. For this reason, there is a need for the development of new interventions to improve and maintain health into old age - to improve "healthspan".

Several mechanisms have been shown to delay the aging process, resulting in improved healthspan in animal models, including mammals. These include caloric restriction, alteration in GH/IGF1 pathways, as well as use of several drugs such as resveratrol (SIRT1 activator) and rapamycin (mTOR inhibitor). At Einstein, the investigators have been working to discover pathways associated with exceptional longevity. The investigators propose the study of drugs already in common clinical use (and FDA approved) for a possible alternative purpose -healthy aging. The investigators goal is to identify additional mechanisms involved in aging, the delay of aging and the prevention of age-related diseases. In this proposal, the investigators explore the possibility of a commonly used drug, metformin, to reverse relevant aspects of the physiology and biology of aging.

Metformin is an FDA approved drug in common use in the US since the 1990s. It is the first-line drug of choice for prevention and treatment of type 2 diabetes (T2DM). The effect of metformin on aging has been extensively studied, and has been associated with longevity in many rodent models. Metformin also extends the lifespan of nematodes, suggesting an evolutionarily conserved mechanism. A recent high impact study demonstrated that metformin reduces oxidative stress and inflammation and extends both lifespan and health span in a mouse model .

If indeed metformin is an "anti-aging" drug, its administration should be associated with less age-related disease in general, rather than the decreased incidence of a single age-related disease. This notion led investigators to further study whether anti-aging effects can be demonstrated in the type 2 diabetes population. Notably, in the United Kingdom Prospective Diabetes Study (UKPDS) metformin, compared with other anti-diabetes drugs, demonstrated a decreased risk of cardiovascular disease. This has been suggested in other studies and meta-analyses and remains an active area of research.

In addition, numerous epidemiologic studies have shown an association of metformin use with a decreased risk of cancer, as well as decreased cancer mortality. There is also evidence from studies performed both in-vitro and in-vivo of metformin's role in attenuating tumorigenesis. The mechanisms proposed relate to its effects on reducing insulin levels, improved insulin action, decreased IGF-1 signaling (central to mammalian longevity), as well as activation of AMP-kinase. In fact, metformin's potential protective effect against cancer has been gaining much attention, with over 100 ongoing studies registered on the Clinical Trials.gov website.

To characterize pathways associated with increased lifespan and healthspan, the investigators plan to compile a repository of muscle and adipose biopsy samples obtained from young healthy subjects and older adults before and after treatment with potential anti-aging drugs. RNA-Seq analysis will be used to identify a unique biological "fingerprint" for aging in these tissues by comparing changes in gene expression in older adults post-drug therapy to the profiles of young healthy subjects. This overall approach is supported by a grant from the Glenn Foundation for the Study of the Biology of Human Aging.

The investigators believe that if metformin changes the biology of aging in tissues to a younger profile, it supports the notion that this drug may have more widespread use - as an "anti-aging" drug.

See the original post:
Metformin in Longevity Study (MILES). - Full Text View ...

Oxid Med Cell Longev. 2009 Nov-Dec; 2(5): 270278.

Department of Biochemistry; University of Allahabad; Allahabad, India

Received 2009 Jul 6; Revised 2009 Jul 12; Accepted 2009 Jul 13.

Polyphenols are secondary metabolites of plants and are generally involved in defense against ultraviolet radiation or aggression by pathogens. In the last decade, there has been much interest in the potential health benefits of dietary plant polyphenols as antioxidant. Epidemiological studies and associated meta-analyses strongly suggest that long term consumption of diets rich in plant polyphenols offer protection against development of cancers, cardiovascular diseases, diabetes, osteoporosis and neurodegenerative diseases. Here we present knowledge about the biological effects of plant polyphenols in the context of relevance to human health.

Key words: polyphenols, antioxidants, bioavailability, human diseases

Polyphenols are naturally occurring compounds found largely in the fruits, vegetables, cereals and beverages. Fruits like grapes, apple, pear, cherries and berries contains up to 200300 mg polyphenols per 100 grams fresh weight. The products manufactured from these fruits, also contain polyphenols in significant amounts. Typically a glass of red wine or a cup of tea or coffee contains about 100 mg polyphenols. Cereals, dry legumes and chocolate also contribute to the polyphenolic intake.1,2

Polyphenols are secondary metabolites of plants and are generally involved in defense against ultraviolet radiation or aggression by pathogens.3 In food, polyphenols may contribute to the bitterness, astringency, color, flavor, odor and oxidative stability. Towards the end of 20th century, epidemiological studies and associated meta-analyses strongly suggested that long term consumption of diets rich in plant polyphenols offered some protection against development of cancers, cardiovascular diseases, diabetes, osteoporosis and neurodegenerative diseases4,5 (). Polyphenols and other food phenolics are the subject of increasing scientific interest because of their possible beneficial effects on human health. This review focuses on the present understanding of the biological effects of dietary polyphenols and their importance in human health and disease.

Pleiotropic health beneficial effects of dietary plant polyphenols: Polyphenols are naturally occurring compounds found largely in the fruits, vegetables, cereals and beverages. These molecules are secondary metabolites of plants and are generally involved in defense against ultraviolet radiation or aggression by pathogens and may also contribute to the bitterness, astringency of the food. Researchers have explored that these molecules are very good antioxidants and may neutralize the destructive reactivity of undesired reactive oxygen/nitrogen species produced as byproduct during metabolic processes in the body. Epidemiological studies have revealed that polyphenols provide a significant protection against development of several chronic diseases such as cardiovascular diseases (CVDs), cancer, diabetes, infections, aging, asthma etc.

More than 8,000 polyphenolic compounds have been identified in various plant species. All plant phenolic compounds arise from a common intermediate, phenylalanine, or a close precursor, shikimic acid. Primarily they occur in conjugated forms, with one or more sugar residues linked to hydroxyl groups, although direct linkages of the sugar (polysaccharide or monosaccharide) to an aromatic carbon also exist. Association with other compounds, like carboxylic and organic acids, amines, lipids and linkage with other phenol is also common.6 Polyphenols may be classified into different groups as a function of the number of phenol rings that they contain and on the basis of structural elements that bind these rings to one another. The main classes include phenolic acids, flavonoids, stilbenes and lignans.2 illustrates the different groups of polyphenols and their chemical structures.

Chemical structures of the different classes of polyphenols. Polyphenols are classified on the basis of the number of phenol rings that they contain and of the structural elements that bind these rings to one another. They are broadly dived in four classes; Phenolic acids, flavonoids, stilbenes and lignans. Phenolic acids are further divided into hydroxyl benzoic and hydroxyl cinnamic acids. Phenolic acids account for about a third of the polyphenolic compounds in our diet and are found in all plant material, but are particularly abundant in acidic-tasting fruits. Caffeic acid, gallic acid, ferulic acid are some common phenolic acids. Flavonoids are most abundant polyphenols in human diet and share a common basic structure consist of two aromatic rings, which are bound together by three carbon atoms that form an oxygenated heterocycle. Biogenetically, one ring usually arises from a molecule of resorcinol, and other ring is derived from the shikimate pathway. Stilbenes contain two phenyl moieties connected by a twocarbon methylene bridge. Most stilbenes in plants act as antifungal phytoalexins, compounds that are synthesized only in response to infection or injury. The most extensively studied stilbene is resveratrol. Lignans are diphenolic compounds that contain a 2,3-dibenzylbutane structure that is formed by the dimerization of two cinnamic acid residues.

Phenolic acids are found abundantly in foods and divided into two classes: derivatives of benzoic acid and derivatives of cinnamic acid. The hydroxybenzoic acid content of edible plants is generally low, with the exception of certain red fruits, black radish and onions, which can have concentrations of several tens of milligrams per kilogram fresh weight.7 The hydroxycinnamic acids are more common than hydroxybenzoic acids and consist chiefly of p-coumaric, caffeic, ferulic and sinapic acids.

Favonoids comprise the most studied group of polyphenols. This group has a common basic structure consisting of two aromatic rings bound together by three carbon atoms that form an oxygenated heterocycle (). More than 4,000 varieties of flavonoids have been identified, many of which are responsible for the attractive colours of the flowers, fruits and leaves.8 Based on the variation in the type of heterocycle involved, flavonoids may be divided into six subclasses: flavonols, flavones, flavanones, flavanols, anthocyanins and isoflavones (). Individual differences within each group arise from the variation in number and arrangement of the hydroxyl groups and their extent of alkylation and/or glycosylation.2 Quercetin, myricetin, catechins etc., are some most common flavonoids.

Chemical structures of sub-classes of flavonoids. Based on the variation in the type of heterocycle involved, flavonoids are divided into six major subclasses: flavonols, flavanones, flavanols, flavones, anthocyanins and isoflavones. Individual differences within each group arise from the variation in number and arrangement of the hydroxyl groups and their extent of alkylation and/or glycosylation. Flavonols (such as quercetin and kaempferol), have a 3-hydroxy pyran-4-one group on the C ring. Flavanones (such as naringenin and taxifolin), have an unsaturated carbon-carbon bond in the C ring. Flavanols (such as the catechins), lack both a 3-hydroxyl group and the 4-one structure in the C ring. Flavones (such as luteolin), lack a hydroxyl group in the 3-position on the C ring. Anthocyanins (such as cyanidin), are characterized by the presence of an oxonium ion on the C ring and are highly coloured as a consequence and in isoflavones (such as genistein), the B ring is attached to the C ring in the 3-position, rather than the 2-position as is the case with the other flavonoids.

Stilbenes contain two phenyl moieties connected by a two-carbon methylene bridge. Occurrence of stilbenes in the human diet is quite low. Most stilbenes in plants act as antifungal phytoalexins, compounds that are synthesized only in response to infection or injury. One of the best studied, naturally occurring polyphenol stilbene is resveratrol (3,4,5-trihydroxystilbene), found largely in grapes. A product of grapes, red wine also contains significant amount of resveratrol.

Lignans are diphenolic compounds that contain a 2,3-dibenzylbutane structure that is formed by the dimerization of two cinnamic acid residues (). Several lignans, such as secoisolariciresinol, are considered to be phytoestrogens. The richest dietary source is linseed, which contains secoisolariciresinol (up to 3.7 g/kg dry weight) and low quantities of matairesinol.9

Distribution of phenolics in plants at the tissue, cellular and sub cellular levels is not uniform. Insoluble phenolics are found in cell walls, while soluble phenolics are present within the plant cell vacuoles.10 Certain polyphenols like quercetin are found in all plant products; fruit, vegetables, cereals, fruit juices, tea, wine, infusions etc., whereas flavanones and isoflavones are specific to particular foods. In most cases, foods contain complex mixtures of polyphenols. The outer layers of plants contain higher levels of phenolics than those located in their inner parts.11 Numerous factors affect the polyphenol content of plants, these include degree of ripeness at the time of harvest, environmental factors, processing and storage. Polyphenolic content of the foods are greatly affected by environmental factors as well as edaphic factors like soil type, sun exposure, rainfall etc. The degree of ripeness considerably affects the concentrations and proportions of various polyphenols.12 In general, it has been observed that phenolic acid content decreases during ripening, whereas anthocyanin concentrations increase. Many polyphenols, especially phenolic acids, are directly involved in the response of plants to different types of stress: they contribute to healing by lignifications of damaged areas possess antimicrobial properties, and their concentrations may increase after infection.13

Another factor that directly affects the polyphenol content of the foods is storage. Studies have proved that polyphenolic content of the foods change on storage, the reason is easy oxidation of these polyphenols.12 Oxidation reactions result in the formation of more or less polymerized substances, which lead to changes in the quality of foods, particularly in color and organoleptic characteristics. Such changes may be beneficial, as is the case with black tea or harmful as in browning of fruit. Storage of wheat flour results in marked loss of phenolic acids.14 After six months of storage, flour contained the same phenolic acids in qualitative terms, but their concentrations were 70% lower compared with fresh. Cold storage, in contrast, has slight effect on the content of polyphenols in apples, pears or onions.15 Cooking also has a major effect on concentration of polyphenols. Onions and tomatoes lose between 75% and 80% of their initial quercetin content after boiling for 15 min, 65% after cooking in a microwave oven, and 30% after frying.16

Bioavailability is the proportion of the nutrient that is digested, absorbed and metabolized through normal pathways. Bioavailability of each and every polyphenol differs however there is no relation between the quantity of polyphenols in food and their bioavailability in human body. Generally, aglycones can be absorbed from the small intestine; however most polyphenols are present in food in the form of esters, glycosides or polymers that cannot be absorbed in native form.17 Before absorption, these compounds must be hydrolyzed by intestinal enzymes or by colonic microflora. During the course of the absorption, polyphenols undergo extensive modification; in fact they are conjugated in the intestinal cells and later in the liver by methylation, sulfation and/or glucuronidation.18 As a consequence, the forms reaching the blood and tissues are different from those present in food and it is very difficult to identify all the metabolites and to evaluate their biological activity.19 Importantly it is the chemical structure of polyphenols and not its concentration that determines the rate and extent of absorption and the nature of the metabolites circulating in the plasma. The most common polyphenols in our diet are not necessarily those showing highest concentration of active metabolites in target tissues; consequently the biological properties of polyphenols greatly differ from one polyphenol to another. Evidence, although indirect, of their absorption through the gut barrier is given by the increase in the antioxidant capacity of the plasma after the consumption of polyphenols-rich foods.20,21

Polyphenols also differs in their site of absorption in humans. Some of the polyphenols are well absorbed in the gastro-intestinal tract while others in intestine or other part of the digestive tract. In foods, all flavonoids except flavanols exist in glycosylated forms. The fate of glycosides in the stomach is not clear yet. Most of the glycosides probably resist acid hydrolysis in the stomach and thus arrive intact in the intestine22 where only aglycones and few glucosides can be absorbed. Experimental studies carried out in rats23 showed that the absorption at gastric level is possible for some flavonoids, such as quercetin, but not for their glycosides. Moreover it has been recently shown that, in rats and mice, anthocyanins are absorbed from the stomach.17,24

It was suggested that glucosides could be transported into enterocytes by the sodium dependent glucose transporter SGLT1, and then hydrolyzed by a cytosolic -glucosidase. However the effect of glucosylation on absorption is less clear for isoflavones than for quercetin.12 Proanthocyanidins differ from most of other plant polyphenols because of their polymeric nature and high molecular weight. This particular feature should limit their absorption through the gut barrier, and oligomers larger than trimers are unlikely to be absorbed in the small intestine in their native forms.17,25

It was observed that the hydroxycinnamic acids, when ingested in the free form, are rapidly absorbed by the small intestine and are conjugated as the flavonoids.26 However these compounds are naturally esterified in plant products and esterification impairs their absorption because intestinal mucosa, liver and plasma do not possess esterases capable of hydrolyzing chlorogenic acid to release caffeic acid, and hydrolysis can be performed only by the microflora present in colon.27 Though most of the poyphenols get absorbed in gastrointestinal tract and intestine but there are some poyphenols which are not absorbed in these locations. These polyphenols reach the colon, where microflora hydrolyze glycosides into aglycones and extensively metabolize these aglycones into various aromatic acids.28

Aglycones are split by the opening of the heterocycle at different points depending on their chemical structure, and thus produce different acids that are further metabolized to derivatives of benzoic acid. After absorption, polyphenols go to several conguation processes. These processes mainly include methylation, sulfation and glucuronidation, representing a metabolic detoxication process, common to many xenobiotics, that facilitates their biliary and urinary elimination by increasing their hydrophilicity. The methylation of poyphenols is also quite specific it generally occurs in the C3-position of the polyphenol, but it could occur in the C4-position: in fact a notable amount of 4-methylepigallocatechin has been detected in human plasma after tea ingestion.29 Enzymes like sulfo-transferases catalyze the transfer of a sulfate moiety during process of sulphonation. The sulfation occurs mainly in the liver, but the position of sulfation for polyphenols have not been clearly identified yet.30 Glucuronidation occurs in the intestine and in the liver, and the highest rate of conjugation is observed in the C3-position.31 The conjugation mechanisms are highly efficient and free aglycones are generally either absent, or present in low concentrations in plasma after consumption of nutritional doses; an exception are green tea catechins, whose aglycones can constitute a significant proportion of the total amount in plasma.32

It is important to identify the circulating metabolites, including the nature and the positions of the conjugating groups on the polyphenol structure, because the positions can affect the biological properties of the conjugates. Polyphenol metabolites circulate in the blood bound to proteins; in particular albumin represents the primary protein responsible for the binding. Albumin plays an important role in bioavailability of polyphenols. The affinity of polyphenols for albumin varies according to their chemical structure.33 Binding to albumin may have consequences for the rate of clearance of metabolites and for their delivery to cells and tissues. It is possible that the cellular uptake of metabolites is proportional to their unbound concentration. Finally, it is still unclear if the polyphenols have to be in the free form to exert their biological activity, or the albumin-bound polyphenols can exert some biological activity.17,34

Accumulation of polyphenols in the tissues is the most important phase of polyphenol metabolism because this is the concentration which is biologically active for exerting the effects of polyphenols. Studies have shown that the polyphenols are able to penetrate tissues, particularly those in which they are metabolized such as intestine and liver. Excretion of polyphenols with their derivatives occurs through urine and bile. It has been observed that the extensively conjugated metabolites are more likely to be eliminated in bile, whereas small conjugates, such as monosulfates, are preferentially excreted in urine. Amount of metabolites excreted in urine is roughly correlated with maximum plasma concentrations. Urinary excretion percentage is quite high for flavanones from citrus fruit and decreases from isoflavones to flavonols. Thus the health beneficial effects of the polyphenols depend upon both the intake and bioavailability.17

Epidemiological studies have repeatedly shown an inverse association between the risk of chronic human diseases and the consumption of polyphenolic rich diet.1,5 The phenolic groups in polyphenols can accept an electron to form relatively stable phenoxyl radicals, thereby disrupting chain oxidation reactions in cellular components.26 It is well established that polyphenol-rich foods and beverages may increase plasma antioxidant capacity. This increase in the antioxidative capacity of plasma following the consumption of polyphenol-rich food may be explained either by the presence of reducing polyphenols and their metabolites in plasma, by their effects upon concentrations of other reducing agents (sparing effects of polyphenols on other endogenous antioxidants), or by their effect on the absorption of pro-oxidative food components, such as iron.1 Consumption of antioxidants has been associated with reduced levels of oxidative damage to lymphocytic DNA. Similar observations have been made with plyphenol-rich food and beverages indicating the protective effects of polyphenols.35 There are increasing evidences that as antioxidants, polyphenols may protect cell constituents against oxidative damage and, therefore, limit the risk of various degenerative diseases associated with oxidative stress.3638

Number of studies has demonstrated that consumption of polyphenols limits the incidence of coronary heart diseases.3941 Atherosclerosis is a chronic inflammatory disease that develops in lesion-prone regions of medium-sized arteries. Atherosclerotic lesions may be present and clinically silent for decades before becoming active and producing pathological conditions such as acute myocardial infarction, unstable angina or sudden cardiac death.42 Polyphenols are potent inhibitors of LDL oxidation and this type of oxidation is considered to be a key mechanism in development of atherosclerosis.43 Other mechanisms by which polyphenols may be protective against cardiovascular diseases are antioxidant, anti-platelet, anti-inflammatory effects as well as increasing HDL, and improving endothelial function.44 Polyphenols may also contribute to stabilization of the atheroma plaque.

Quercetin, the abundant polyphenol in onion has been shown to be inversely associated with mortality from coronary heart disease by inhibiting the expression of metalloproteinase 1 (MMP1), and the disruption of atherosclerotic plaques.44 Tea catechins have been shown to inhibit the invasion and proliferation of the smooth muscle cells in the arterial wall, a mechanism that may contribute to slow down the formation of the atheromatous lesion.45 Polyphenols may also exert antithrombotic effects by means of inhibiting platelet aggregation. Consumption of red wine or non-alcoholic wine reduces bleeding time and platelet aggregation. Thrombosis induced by stenosis of coronary artery is inhibited when red wine or grape juice is administrated.46 Polyphenols can improve endothelial dysfunction associated with different risk factors for atherosclerosis before the formation of plaque; its use as a prognostic tool for coronary heart diseases has also been proposed.47 It has been observed that consumption of black tea about 450 ml increases artery dilation 2 hours after intake and consumption of 240 mL red wine for 30 days countered the endothelial dysfunction induced by a high fat diet.48 Long term regular intake of black tea was found to lower blood pressure in a cross-sectional study of 218 women above 70 years of age. Excretion of 4-O-methylgallic acid (4OMGA, a biomarker for tea polyphenols in body) was monitored. A higher consumption of tea and therefore higher excretion of 4OMGA were associated with lower blood pressure (BP). Tea polyphenols may be the components responsible for the lowering of BP. The effect may be due to antioxidant activity as well as improvement of endothelial function or estrogen like activity.44

Resveratrol, the wine polyphenol prevents the platelet aggregation via preferential inhibition of cyclooxygenase 1(COX 1) activity, which synthesizes thromboxane A2, an inducer of the platelet aggregation and vasoconstrictor.49 In addition to this, resveratrol is capable of relaxing the isolated arteries and rat aortic rings. The ability to stimulate Ca++-activated K+ channels and to enhance nitric oxide signaling in the endothelium are other pathways by which resveratrol exerts vasorelaxant activity.49,50 Direct relation between cardiovascular diseases (CVDs) and oxidation of LDL is now well established. Oxidation of LDL particles is strongly associated with the risk of coronary heart diseases and myocardial infarctions. Studies have shown that resveratrol potentially inhibits the oxidation of the LDL particles via chelating copper or by direct scavenging of the free radicals. Resveratrol is the active compound in red wine which is attributed for French Paradox, the low incidence of CVD despite the intake of high-fat diet and smoking among French.51,52 Association between polyphenol intake or the consumption of polyphenol-rich foods and incident of cardiovascular diseases were also examined in several epidemiological studies and it was found that consumption of polyphenol rich diet have been associated to a lower risk of myocardial infarction in both case-control and cohort studies.53

Effect of polyphenols on human cancer cell lines, is most often protective and induce a reduction of the number of tumors or of their growth.54 These effects have been observed at various sites, including mouth, stomach, duodenum, colon, liver, lung, mammary gland or skin. Many polyphenols, such as quercetin, catechins, isoflavones, lignans, flavanones, ellagic acid, red wine polyphenols, resveratrol and curcumin have been tested; all of them showed protective effects in some models although their mechanisms of action were found to be different.55

Development of cancer or carcinogenesis is a multistage and microevolutionary process. Into the three major stages of carcinogenesis: initiation, promotion and progression. Initiation is a heritable aberration of a cell. Cells so initiated can undergo transformation to malignancy if promotion and progression follow. Promotion, on the other hand, is affected by factors that do not alter DNA sequences and involves the selection and clonal expansion of initiated cells.

Several mechanisms of action have been identified for chemoprevention effect of polyphenols, these include estrogenic/antiestrogenic activity, antiproliferation, induction of cell cycle arrest or apoptosis, prevention of oxidation, induction of detoxification enzymes, regulation of the host immune system, anti-inflammatory activity and changes in cellular signaling.44

Polyphenols influence the metabolism of pro-carcinogens by modulating the expression of cytochrome P450 enzymes involved in their activation to carcinogens. They may also facilitate their excretion by increasing the expression of phase II conjugating enzymes. This induction of phase II enzymes may have its origin in the toxicity of polyphenols.1 Polyphenols can form potentially toxic quinones in the body that are, themselves, substrates of these enzymes. The intake of polyphenols could then activate these enzymes for their own detoxication and, thus, induce a general boosting of our defenses against toxic xenobiotics.56 It has been demonstrated that tea catechins in the form of capsules when given to men with high-grade prostate intraepithelial neoplasia (PIN) demonstrated cancer preventive activity by inhibiting the conversion of high grade PIN lesions to cancer.57

Theaflavins and thearubigins, the abundant polyphenols in black tea have also been shown to possess strong anticancer property. Black tea polyphenols were found to inhibit proliferation and increase apoptosis in Du 145 prostate carcinoma cells. Higher level of insulin like growth factor-1 (IGF-1) was found to be associated with a higher risk of development of prostate cancer. IGF-1 binding to its receptor is a part of signal transduction pathway which causes cell proliferation.58 Black tea polyphenol addition was found to block IGF-1 induced progression of cells into S phase of cell cycle at a dose of 40 mg/ml in prostate carcinoma cells.58

Quercetin has also been reported to possess anticancer property against benzo(a)pyrene induced lung carcinogenesis in mice, an effect attrtibuted to its free radical scavenging activity.59 Resveratrol prevents all stages of development of cancer and has been found to be effective in most types of cancer including lung, skin, breast, prostate, gastric and colorectal cancer. It has also been shown to suppress angiogenesis and metastasis. Extensive data in human cell cultures indicate that resveratrol can modulate multiple pathways involved in cell growth, apoptosis and inflammation. The anti-carcinogenic effects of resveratrol appears to be closely associated with its antioxidant activity, and it has been shown to inhibit cyclooxygenase, hydroperoxidase, protein kinase C, Bcl-2 phosphorylation, Akt, focal adhesion kinase, NFB, matrix metalloprotease-9 and cell cycle regulators.60 These and other in vitro and in vivo studies provide a rationale in support of the use of dietary polyphenols in human cancer chemoprevention, in a combinatorial approach with either chemotherapeutic drugs or cytotoxic factors for efficient treatment of drug refractory tumor cells.

Impairment in glucose metabolism leads to physiological imbalance with the onset of the hyperglycemia and subsequently diabetes mellitus. There are two main categories of diabetes; type-1 and type-2. Studies have shown that several physiological parameters of the body get altered in the diabetic conditions.61,62 Long term effects of diabetes include progressive development of specific complements such as retinopathy, which affects eyes and lead to blindness; nephropathy in which the renal functions are altered or disturbed and neuropathy which is associated with the risks of amputations, foot ulcers and features of autonomic disturbance including sexual dysfunctions. Numerous studies report the antidiabetic effects of polyphenols. Tea catechins have been investigated for their anti-diabetic potential.63,64 Polyphenols may affect glycemia through different mechanisms, including the inhibition of glucose absorption in the gut or of its uptake by peripheral tissues. The hypoglycemic effects of diacetylated anthocyanins at a 10 mg/kg diet dosage were observed with maltose as a glucose source, but not with sucrose or glucose.65 This suggests that these effects are due to an inhibition of -glucosidase in the gut mucosa. Inhibition of -amylase and sucrase in rats by catechin at a dose of about 50 mg/kg diet or higher was also observed.

The inhibition of intestinal glycosidases and glucose transporter by polyphenols has been studied.66 Individual polyphenols, such as (+)catechin, ()epicatechin, ()epigallocatechin, epicatechin gallate, isoflavones from soyabeans, tannic acid, glycyrrhizin from licorice root, chlorogenic acid and saponins also decrease S-Glut-1 mediated intestinal transport of glucose. Saponins additionally delay the transfer of glucose from stomach to the small intestine.67 Resveratrol has also been reported to act as an anti-diabetic agent. Many mechanisms have been proposed to explain the anti-diabetic action of this stilbene, modulation of SIRT1 is one of them which improves whole-body glucose homeostasis and insulin sensitivity in diabetic rats.50,68 It is reported that in cultured LLC-PK1 cells, high glucose induced cytotoxicity and oxidative stress was inhibited by grape seed polyphenols. Resveratrol inhibits diabetes-induced changes in the kidney (diabetic nephropathy) and significantly ameliorates renal dysfunction and oxidative stress in diabetic rats. Treatment with resveratrol also decreased insulin secretion and delayed the onset of insulin resistance. A possible mechanism was thought to be related to the inhibition of K + ATP and K + V channel in beta cells.69

Onion polyphenols, especially quercetin is known to possess strong anti diabetic activity. A recent study shows that quercetin has ability to protect the alterations in diabetic patients during oxidative stress. Quercetin significantly protected the lipid peroxidation and inhibition antioxidant system in diabetics.70 Hibiscus sabdariffa extract contains polyphenolic acids, flavonoids, protocatechuic acid and anthocyanins. A study performed by Lee et al.71 showed that polyphenols present in the extracts from Hibiscus sabdariffa attenuate diabetic nephropathy including pathology, serum lipid profile and oxidative markers in kidney. Ferulic acid (FA) is another polyphenol very abundant in vegetables and maize bran. Several lines of evidence have shown that FA acts as a potent anti-diabetic agent by acting at many levels. It was demonstrated that FA lowered blood glucose followed by a significantly increased plasma insulin and a negative correlation between blood glucose and plasma insulin.72,73

Aging is the accumulation process of diverse detrimental changes in the cells and tissues with advancing age, resulting in an increase in the risks of disease and death. Among many theories purposed for the explaining the mechanism of aging, free radical/oxidative stress theory is one of the most accepted one.74 A certain amount of oxidative damage takes place even under normal conditions; however, the rate of this damage increases during the aging process as the efficiency of antioxidative and repair mechanisms decrease.75,76 Antioxidant capacity of the plasma is related to dietary intake of antioxidants; it has been found that the intake of antioxidant rich diet is effective in reducing the deleterious effects of aging and behavior. Several researches suggest that the combination of antioxidant/anti-inflammatory polyphenolic compounds found in fruits and vegetables may show efficacy as anti-aging compounds.77,78 Subset of the flavonoids known as anthocyanins, are particularly abundant in brightly colored fruits such as berry fruits and concord grapes and grape seeds. Anthocyanins are responsible for the colors in fruits, and they have been shown to have potent antioxidant/anti-inflammatory activities, as well as to inhibit lipid peroxidation and the inflammatory mediators cyclo-oxygenase (COX)-1 and -2.79

Fruit and vegetable extracts that have high levels of flavonoids also display high total antioxidant activity such as spinach, strawberries and blueberries. It is reported that the dietary supplementations (for 8 weeks) with spinach, strawberry or blueberry extracts in a control diet were also effective in reversing age-related deficits in brain and behavioral function in aged rats.80 A recent study demonstrates that the tea catechins carry strong anti-aging activity and consuming green-tea rich in these catechins, may delay the onset of aging.81

Polyphenols are also beneficial in ameliorating the adverse effects of the aging on nervous system or brain. Paramount importance for the relevance of food polyphenols in the protection of the aging brain is the ability of these compounds to cross the blood-brain barrier (BBB), which tightly controls the influx in the brain of metabolites and nutrients as well as of drugs. Resveratrol has been found to consistently prolong the life span; its action is linked to an event called caloric restriction or partial food deprivation.50

Grape polyphenol, resveratrol is very recent entry as an antiaging agent. It has been shown that the early target of the resveratrol is the sirtuin class of nicotinamide adenine dinucleotide (NAD)-dependent deacetylases. Seven sirtuins have been identified in mammals, of which SIRT-1 is believed to mediate the beneficial effects on health and longevity of both caloric restriction and resveratrol.82 Resveratrol increased insulin sensitivity, decreased the expression of IGF-1 and increased AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-c coactivator 1a (PGC-1a) activity. When examined for the mechanism, it activated forkhead box O (FOXO), which regulates the expression of genes that contribute both to longevity and resistance to various stresses and insulin-like growth factorbinding protein 1 (IGFBP-1).83 There are experimental evidences that resveratrol can extend lifespan in the yeast Saccharomyces cerevisiae, the fruit fly Drosophila melanogaster, the nematode worm C. elegans, and seasonal fish Nothobranchius furzeri.52 Recently quercetin has also been reported to exert preventive effect against aging.84

Oxidative stress and damage to brain macromolecules is an important process in neurodegenerative diseases. Alzheimers disease is one of the most common occurring neurodisorder affecting up to 18 million people worldwide. Because polyphenols are highly antioxidative in nature, their consumption may provide protection in neurological diseases.85 It was observed that the people drinking three to four glasses of wine per day had 80% decreased incidence of dementia and Alzheimers disease compared to those who drank less or did not drink at all.86

Resveratrol, abundantly present in wine scavenges O2 and OH in vitro, as well as lipid hydroperoxyl free radicals, this efficient antioxidant activity is probably involved in the beneficial effect of the moderate consume of red wine against dementia in the elderly. Resveratrol inhibits nuclear factor B signaling and thus gives protection against microglia-dependent -amyloid toxicity in a model of Alzheimers disease and this activity is related with the activation of the SIRT-1.82 It was found that the consumption of fruit and vegetable juices containing high concentrations of polyphenols, at least three times per week, may play an important role in delaying the onset of Alzheimers disease.87 Polyphenols from fruits and vegetables seem to be invaluable potential agents in neuroprotection by virtue of their ability to influence and modulate several cellular processes such as signaling, proliferation, apoptosis, redox balance and differentiation.88

Recently Aquilano et al.89 reported that administration of polyphenols provide protective effects against Parkinsons disease, a neurological disorder characterized by degeneration of dopaminergic neurons in the substantia nigra zona compacta. Nutritional studies have linked the consumption of green tea to the reduced risk of developing Parkinsons disease. In animal models epigallocatechin gallate (EGCG) has been shown to exert a protective role against the neurotoxin MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), an inducer of a Parkinsons-like disease, either by competitively inhibiting the uptake of the drug, due to molecular similarity or by scavenging MPTP-mediated radical formation. EGCG may also protect neurons by activating several signaling pathways, involving MAP kinases which are fundamental for cell survival.90 The therapeutic role of catechins in Parkinsons disease is also due to their ability to chelate iron. This property contributes to their antioxidant activity by preventing redox-active transition metal from catalyzing free radicals formation. Moreover, the antioxidant function is also related to the induction of the expression of antioxidant and detoxifying enzymes particularly in the brain, which is not sufficiently endowed of a well-organized antioxidant defense system.89 Maize bran polyphenol, ferulic acid is also reported to be beneficial in Alzheimers disease. This effect is due to its antioxidant and anti-inflammatory properties.72

Except above explained pathological events, polyphenols show several other health beneficial effects. Dietary polyphenols exert preventive effects in treatment of asthma. In asthma the airways react by narrowing or obstructing when they become irritated. This makes it difficult for the air to move in and out. This narrowing or obstruction can cause one or a combination of symptoms such as wheezing, coughing, shortness of breath and chest tightness. Epidemiological evidence that polyphenols might protect against obstructive lung disease come from studies that have reported negative associations of apple intake with prevalence and incidence of asthma, and a positive association with lung function.91,92 Increased consumption of the soy isoflavone, genistein, was associated with better lung function in asthmatic patients.93 Intake of polyphenols is also reported as beneficial in osteoporosis. Supplementation of diet with genistein, daidzein or their glycosides for several weeks prevents the loss of bone mineral density and trabecular volume caused by the ovariectomy.94 Polyphenols also protect skin damages induced from sunlight. Study on animals provide evidence that polyphenols present in the tea, when applied orally or topically, ameliorate adverse skin reactions following UV exposure, including skin damage, erythema and lipid peroxidation.95

Black tea polyphenols are reported to be helpful in mineral absorption in intestine as well as to possess antiviral activity. Theaflavins present in black tea were found to have anti HIV-1 activity. These polyphenols inhibited the entry of HIV-1 cells into the target cells. HIV-1 entry into the target cell involves fusion of glycoprotein (GP) and envelope of the virus with the cell membrane of the host cells. Haptad repeat units present at N and C terminals of GP41 (membrane protein) on the viral envelope, fuse to form the fusion active GP41 core, which is a six-helical bundle. Theaflavins were found to block the formation of this six-helix bundle required for entry of the virus into the host.58 Theaflavin 3 3 digallate, and theaflavin 3 gallate were found to inhibit Severe Acute Respiratory Syndrome (SARS) corona virus. This antiviral activity was due to inhibition of the chymotrypsin like protease (3CL Pro) which is involved in the proteolytic processing during viral multiplication.58

The results of studies outlined in this review provide a current understanding on the biological effects of polyphenols and their relevance to human health. Polyphenols or polyphenol rich diets provide significant protection against the development and progression of many chronic pathological conditions including cancer, diabetes, cardio-vascular problems and aging. Although several biological effects based on epidemiological studies can be scientifically explained, the mechanism of action of some effects of polyphenols is not fully understood. A better knowledge of some variables of polyphenol bioavailability; such as the kinetics of absorption, accumulation and elimination, will facilitate the design of such studies. The role of polyphenols in human health is still a fertile area of research. Based on our current scientific understanding, polyphenols offer great hope for the prevention of chronic human diseases.

K.B.P. is a recipient of Senior Research Fellowship form Council of Scientific & Industrial Research (CSIR), India.

Continued here:
Plant polyphenols as dietary antioxidants in human health ...

The scientific community has traditionally associated aspects of biomedical research findings in animal models, such as lab mice, with humans. But that is not the case with fasting blood glucose levels, a common metabolic test, according to new research led by NIA scientists. The results were published in Cell Metabolism.

One obstacle in this translational puzzle is the lack of long-term mouse population research that can be directly compared to human aging studies of health and disease. To address this challenge, the NIA team developed the first mouse longitudinal cohort study to examine common metrics of aging across the entire lifespan, known as the Study of Longitudinal Aging in Mice (SLAM).

Aging naturally can lead to significant changes in weight, body fat percentage, and glucose metabolism in humans. Translating these metabolic shifts from animal models to humans has been imperfect at best. This has slowed progress in developing and testing potential interventions to delay the onset of metabolic problems and help promote healthy aging and longevity.

This study explored several measures of metabolism shared in previous and ongoing research by NIA-supported scientists at The Jackson Laboratory, University of Wisconsin, and Indiana University using animal models (in those cases mice and nonhuman primates) and human studies. The investigators for this new research tracked body composition, fasting glucose, and body weight, along with related mortality rates, to compare differences and similarities across species. In addition to SLAM and primate data, the team looked at participant data from the NIA-supported Baltimore Longitudinal Study of Aging (BLSA), the nations longest continual study of human aging.

In all three species, body fat percentage usually increases steadily up until around age 70, then begins to decline. Humans tend to have progressive increases in fasting blood glucose levels with age, even if they do not develop type 2 diabetes. Similar patterns were found in nonhuman primates.

But when it came to the SLAM mice, very different patterns were found for blood glucose. The research team was intrigued to find that the mices blood glucose levels stayed relatively stable across the middle of their lifespans, and then decreased as they grew older. Mice with high levels of glucose later in life tended to live longer, the opposite trend from humans and nonhuman primates, who tend to live longer when they have lower glucose levels.

The research team views these results as a new and important finding for aging research using common animal models and as a cautionary tale when translating age-associated metabolic trends from mice to humans. They hope this new finding can inform future studies using mouse models to develop metabolic and glucose regulation drugs aimed at older adult humans. In other words, drugs that are meant to correct elevated blood glucose for humans would not translate well for mouse studies of efficacy and safety. Conversely, drugs that lower glucose in mice may not extend their healthy lifespan but could still be worth pursuing in studies in nonhuman primates and eventually humans.

This research was supported by the NIA Intramural Research Program grant 1ZIAAG000344-02 and NIH grants P01AG011915, R01AG040178, R56AG047358, P51RR000167/P51OD011106, and P30AG038070.

Reference: Palliyaguru, Dushani L et al. Fasting blood glucose as a predictor of mortality: Lost in translation.Cell Metabolism. 2021; S1550-4131(21)00376-4. doi:10.1016/j.cmet.2021.08.013.

Continue reading here:
Researchers caution against associating animal with human fasting blood glucose levels to predict health and longevity - National Institute on Aging